Oppenheimer Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $73

Futu News21:35 · Ratings

H.C. Wainwright Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $81

Futu News19:31 · Ratings

A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $55 to $92

Futu NewsJan 11 21:00 · Ratings

Express News | Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsJan 11 06:15

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireJan 11 06:15

Crinetics Pharmaceuticals' Atumelnant Trial Data Prompts Hold Rating Amid Efficacy and Safety Concerns

TipRanksJan 11 03:36 · Ratings